Levente Szalárdy

2.4k total citations · 1 hit paper
37 papers, 1.4k citations indexed

About

Levente Szalárdy is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Levente Szalárdy has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Physiology and 10 papers in Neurology. Recurrent topics in Levente Szalárdy's work include Tryptophan and brain disorders (9 papers), Mitochondrial Function and Pathology (7 papers) and Alzheimer's disease research and treatments (6 papers). Levente Szalárdy is often cited by papers focused on Tryptophan and brain disorders (9 papers), Mitochondrial Function and Pathology (7 papers) and Alzheimer's disease research and treatments (6 papers). Levente Szalárdy collaborates with scholars based in Hungary, Austria and Canada. Levente Szalárdy's co-authors include László Vécsei, József Toldi, Ferenc Fülöp, Péter Klivènyi, Dénes Zádori, Gábor Veres, Lars Edvinsson, János Tajti, Rita Maszlag-Török and Krisztina Bencsik and has published in prestigious journals such as Nature Reviews Drug Discovery, International Journal of Molecular Sciences and Behavioural Brain Research.

In The Last Decade

Levente Szalárdy

36 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kynurenines in the CNS: recent advances and new questions

2012 504 citations László Vécsei, Levente Szalárdy et al. Nature Reviews Drug Discovery profile →

Peers

Levente Szalárdy

PMH

PHYSI

Dénes Zádori Hungary

Ewa Obuchowicz Poland

Bianca Pfaffenseller Brazil

Jue He China

Marc‐Olivier Trépanier Canada

Ana M. Espinosa‐Oliva Spain

Jeremy W. Gawryluk United States

Zelan Wei Canada

Beatriz Gomez Perez‐Nievas Spain

Sophie Imbeault Sweden

Dénes Zádori Hungary

Levente Szalárdy

561 ×0.9

600 ×1.4

289 ×0.9

PMH

291 ×1.0

396 ×1.4

PHYSI

Citations per year, relative to Levente Szalárdy Levente Szalárdy (= 1×) peers Dénes Zádori

Countries citing papers authored by Levente Szalárdy

Since Specialization

Citations

This map shows the geographic impact of Levente Szalárdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levente Szalárdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levente Szalárdy more than expected).

Fields of papers citing papers by Levente Szalárdy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levente Szalárdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levente Szalárdy. The network helps show where Levente Szalárdy may publish in the future.

Co-authorship network of co-authors of Levente Szalárdy

This figure shows the co-authorship network connecting the top 25 collaborators of Levente Szalárdy. A scholar is included among the top collaborators of Levente Szalárdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levente Szalárdy. Levente Szalárdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehoczki, Andrea, et al.. (2025). Intracerebral Hemorrhage in Aging: Pathophysiology, Clinical Challenges, and Future Directions. Life. 15(10). 1569–1569. 1 indexed citations

Szalárdy, Levente, et al.. (2025). Distinct cerebral amyloid angiopathy patterns in adult Down syndrome. Journal of the Neurological Sciences. 476. 123601–123601. 1 indexed citations

Reisz, Zita, Cecília Rajda, László Vécsei, et al.. (2020). A longitudinally extensive H3 K27M-mutant diffuse midlineglioma in an elderly patient clinically mimicking central nervoussystem inflammation: a case report. Folia Neuropathologica. 58(4). 377–385. 3 indexed citations

Reisz, Zita, et al.. (2020). Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy. Journal of Neural Transmission. 127(6). 963–972. 17 indexed citations

Edvinsson, Lars, János Tajti, Levente Szalárdy, & László Vécsei. (2018). PACAP and its role in primary headaches. The Journal of Headache and Pain. 19(1). 21–21. 89 indexed citations

Szalárdy, Levente, Dénes Zádori, Krisztina Bencsik, László Vécsei, & Péter Klivènyi. (2017). Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis. Neuroscience Letters. 651. 128–133. 9 indexed citations

Zádori, Dénes, Gábor Veres, Levente Szalárdy, et al.. (2016). Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012–2015). Expert Opinion on Therapeutic Patents. 26(7). 815–832. 13 indexed citations

Szalárdy, Levente, Rita Maszlag-Török, Dénes Zádori, et al.. (2016). Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy. Folia Neuropathologica. 1(1). 9–22. 14 indexed citations

Szalárdy, Levente, Dénes Zádori, Péter Klivènyi, & László Vécsei. (2016). The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer’s Disease: Shortcomings in Prodromal Diagnosis. Journal of Alzheimer s Disease. 53(2). 373–392. 8 indexed citations

10.

Maszlag-Török, Rita, et al.. (2016). High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice. Acta Neurobiologiae Experimentalis. 76(3). 176–181. 8 indexed citations

11.

Szalárdy, Levente, Rita Maszlag-Török, Dénes Zádori, et al.. (2016). Lack of age-related clinical progression in PGC-1α-deficient mice – implications for mitochondrial encephalopathies. Behavioural Brain Research. 313. 272–281. 9 indexed citations

12.

Zádori, Dénes, Gábor Veres, Levente Szalárdy, Péter Klivènyi, & László Vécsei. (2015). Drug-induced movement disorders. Expert Opinion on Drug Safety. 14(6). 877–890. 23 indexed citations

13.

Veres, Gábor, Dénes Zádori, Levente Szalárdy, et al.. (2015). Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease. Pharmacology Biochemistry and Behavior. 132. 115–124. 20 indexed citations

14.

Zádori, Dénes, et al.. (2013). Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.. PubMed. 66(11-12). 407–14. 2 indexed citations

15.

Szalárdy, Levente, Dénes Zádori, Mihaela Simu, et al.. (2013). Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis. Neuroscience Letters. 554. 131–134. 26 indexed citations

16.

Szalárdy, Levente, Dénes Zádori, László Vécsei, et al.. (2013). Neuropathology of Partial PGC-1α Deficiency Recapitulates Features of Mitochondrial Encephalopathies but Not of Neurodegenerative Diseases. Neurodegenerative Diseases. 12(4). 177–188. 16 indexed citations

17.

Szalárdy, Levente, Dénes Zádori, Mihaela Simu, et al.. (2013). Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity. Journal of the Neurological Sciences. 331(1-2). 38–42. 51 indexed citations

18.

Vécsei, László, Levente Szalárdy, Ferenc Fülöp, & József Toldi. (2012). Kynurenines in the CNS: recent advances and new questions. Nature Reviews Drug Discovery. 12(1). 64–82. 504 indexed citations breakdown →

19.

Zádori, Dénes, Péter Klivènyi, Levente Szalárdy, et al.. (2012). Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders. Journal of the Neurological Sciences. 322(1-2). 187–191. 80 indexed citations

20.

Zádori, Dénes, Levente Szalárdy, József Toldi, et al.. (2012). Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease. Journal of Neural Transmission. 120(4). 673–681. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact